4583 On Other Exchanges
4583 is not on other exchanges.

chiome bioscience inc (4583) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CHIOME BIOSCIENCE INC (4583)

Related News

No related news articles were found.

chiome bioscience inc (4583) Related Businessweek News

No Related Businessweek News Found

chiome bioscience inc (4583) Details

Chiome Bioscience Inc. is engaged in the research and development of drug discovery platform technology worldwide. It helps drug discovery companies, such as drug manufacturers and biotech companies to develop antibody drugs through programs based on the autonomously diversifying library system (ADLib system). The ADLib system is a monoclonal antibody generating system that provides various arrays of antibodies in vitro, without using immunization. The company develops the ADLib system to generate therapeutics antibodies; and licenses novel therapeutic antibodies for antigens to pharmaceutical manufactures. Chiome Bioscience Inc. was founded in 2005 and is headquartered in Tokyo, Japan.

Founded in 2005

chiome bioscience inc (4583) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chiome bioscience inc (4583) Key Developments

Chiome Bioscience Inc. Announces Non-Consolidated Earnings Results for the Six Months Ended June 30, 2016

Chiome Bioscience Inc. announced non-consolidated earnings results for the six months ended June 30, 2016. For the period, the company reported net sales of JPY 130 million, operating loss was JPY 582 million, ordinary loss was JPY 580 million and net loss was JPY 711 million or net loss per share of JPY 31.99. Net cash used in operating activities was JPY 569,648,000. Purchase of property and equipment was JPY 5,916,000.

Chiome Bioscience Inc., Q2 2016 Earnings Call, Aug 22, 2016

Chiome Bioscience Inc., Q2 2016 Earnings Call, Aug 22, 2016

Chiome Bioscience Inc. to Report Q2, 2016 Results on Aug 12, 2016

Chiome Bioscience Inc. announced that they will report Q2, 2016 results on Aug 12, 2016


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4583 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4583.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4583 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 41.8x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.6x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHIOME BIOSCIENCE INC, please visit www.chiome.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.